Decreased hepatic microsomal cytochrome P450 due to indomethacin: Protective roles of 16,16-dimethylprostaglandin F2α and inducing agents
- 1 February 1983
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 32 (3) , 389-397
- https://doi.org/10.1016/0006-2952(83)90516-6
Abstract
No abstract availableThis publication has 29 references indexed in Scilit:
- Altered zinc homeostasis and hepatic accumulation of metallothionein in indomethacin-induced enteropathyToxicology and Applied Pharmacology, 1979
- The effect of dietary vitamin E on indomethacin stimulated chemiluminescense in rat liver microsomesProstaglandins and Medicine, 1979
- Inhibition of hepatic drug-metabolizing enzymes by arachidonic acidXenobiotica, 1979
- Studies on the mechanism of spironolactone protection against indomethacin toxicityToxicology and Applied Pharmacology, 1976
- The Effects of the Non-ionic Detergent Tween 80 on Hepatic Microsomal HydroxylationXenobiotica, 1975
- Renal and gastric lesions after phenylbutazone and indomethacin in the ratPathology, 1974
- Strain-dependent renal toxicity of a nonsteroid antiinflammatory agentToxicology and Applied Pharmacology, 1971
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970
- Jejunal ulcers produced by indomethacinJournal of Pharmacy and Pharmacology, 1969
- Side-effects of indomethacin.Annals of the Rheumatic Diseases, 1967